Ian Lai
Impact in
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 3
-
- Cancer, Lipids, and Metabolism 2
- MicroRNA in disease regulation 1
- Co-authors
- Renumathy Dhanasekaran (4 shared papers)Dean W. Felsher (7 shared papers)Virginie Baylot (3 shared papers)Adriane Mosley (3 shared papers)Meital Gabay (2 shared papers)Srividya Swaminathan (2 shared papers)Sibu Kuruvilla (2 shared papers)Nia Adeniji (2 shared papers)
- Journals
- Cancer Research (3 papers)eLife (2 papers)Journal for ImmunoTherapy of Cancer (1 paper)Oncotarget (1 paper)Cell chemical biology (1 paper)
- Partner nations
- United StatesTaiwanIndia
In The Last Decade
Ian Lai
8 papers receiving 260 citations
Peers
Comparison fields: 5 of 46
- Cancer Research 73
- Immunology 85
- Oncology 84
- Molecular Biology 165
- Hepatology 19
Countries citing papers authored by Ian Lai
This map shows the geographic impact of Ian Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian Lai more than expected).
Fields of papers citing papers by Ian Lai
This network shows the impact of papers produced by Ian Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian Lai. The network helps show where Ian Lai may publish in the future.
Co-authors
The 25 scholars most cited alongside Ian Lai, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 109 | |
| 2 | 2020 | 46 | |
| 3 | 2017 | 38 | |
| 4 | 2022 | 31 | |
| 5 | 2022 | 28 | |
| 6 | 2021 | 6 | |
| 7 | 2023 | 1 | |
| 8 | 2021 | 1 | |
| 9 | 2025 | 0 |
About Ian Lai
Ian Lai is a scholar working on Molecular Biology, Cancer Research, Immunology, Oncology and Pathology and Forensic Medicine, having authored 9 papers that have together received 260 indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (3 papers), Cancer, Lipids, and Metabolism (2 papers), Immunotherapy and Immune Responses (2 papers), Immune cells in cancer (2 papers), Immune Cell Function and Interaction (2 papers), Cancer Immunotherapy and Biomarkers (2 papers), Hepatocellular Carcinoma Treatment and Prognosis (1 paper) and MicroRNA in disease regulation (1 paper). The work is most often cited by research in Cancer Research (73 citations), Immunology (85 citations), Oncology (84 citations), Molecular Biology (165 citations) and Hepatology (19 citations). Ian Lai has collaborated with scholars based in United States, Taiwan and India. Frequent co-authors include Renumathy Dhanasekaran, Dean W. Felsher, Virginie Baylot, Adriane Mosley, Meital Gabay, Srividya Swaminathan, Sibu Kuruvilla, Nia Adeniji, Ling Tong and Phuoc T. Tran. Their work appears in journals such as Cancer Research, eLife, Journal for ImmunoTherapy of Cancer, Oncotarget and Cell chemical biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.